| (-)-epigallocatechin 3-gallate | increases activity | ISO | RGD:68468 | 6480464 | epigallocatechin gallate results in increased activity of POR protein | CTD | PMID:15998352 |
| (2,4,5-trichlorophenoxy)acetic acid | decreases expression | EXP | | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of POR mRNA | CTD | PMID:18579281 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | CYP1A1 protein affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]]; more ... | CTD | PMID:21932800 |
| (R)-lipoic acid | decreases activity | ISO | RGD:68468 | 6480464 | Thioctic Acid results in decreased activity of POR protein | CTD | PMID:16391466 |
| 1,2,4-trimethylbenzene | decreases expression | ISO | RGD:68335 | 6480464 | pseudocumene results in decreased expression of POR protein | CTD | PMID:17337753 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POR mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of POR mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POR mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:68468 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of POR mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:68335 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of POR mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:68335 | 6480464 | Tetrachlorodibenzodioxin affects the expression of POR mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:68335 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:68468 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of POR mRNA | CTD | PMID:20106945 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:68335 | 6480464 | 2,4-dinitrotoluene affects the expression of POR mRNA | CTD | PMID:21346803 |
| 2,6-dichlorobenzonitrile | decreases response to substance | EXP | | 6480464 | POR protein results in decreased susceptibility to dichlobanil | CTD | PMID:20840855 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:68335 | 6480464 | 2,6-dinitrotoluene affects the expression of POR mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:68335 | 6480464 | 2-Acetylaminofluorene results in increased expression of POR mRNA | CTD | PMID:15089088 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of POR mRNA] | CTD | PMID:19467301 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of POR mRNA | CTD | PMID:20188158 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of POR mRNA | CTD | PMID:16054899 |
| 3H-1,2-dithiole-3-thione | affects expression | ISO | RGD:68335 | 6480464 | 1,2-dithiol-3-thione affects the expression of POR mRNA | CTD | PMID:19162173 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | affects response to substance | EXP | | 6480464 | POR affects the susceptibility to 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:22710403 |
| 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein] | CTD | PMID:22595614 |
| 7,12-dimethyltetraphene | decreases abundance | EXP | | 6480464 | POR protein results in decreased abundance of 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:22595614 |
| 8-hydroxy-2'-deoxyguanosine | multiple interactions | ISO | RGD:68335 | 6480464 | [Nitrofurazone co-treated with POR protein co-treated with Copper] results in increased abundance of 8-oxo-7-hydrodeoxyguanosine | CTD | PMID:15488632 |
| acetic acid | increases metabolic processing | ISO | RGD:68335 | 6480464 | POR protein results in increased metabolism of Acetic Acid analog | CTD | PMID:21933969 |
| acetic acid | increases metabolic processing | ISO | RGD:68468 | 6480464 | POR protein results in increased metabolism of Acetic Acid analog | CTD | PMID:21933969 |
| acetylsalicylic acid | decreases expression | ISO | RGD:68468 | 6480464 | Aspirin results in decreased expression of POR mRNA | CTD | PMID:15928584 |
| aflatoxin B1 | affects expression | ISO | RGD:68468 | 6480464 | Aflatoxin B1 affects the expression of POR protein | CTD | PMID:20106945 |
| aflatoxin B1 | multiple interactions | ISO | RGD:68468 | 6480464 | [CYP3A7 co-treated with POR] results in increased susceptibility to Aflatoxin B1 | CTD | PMID:7625840 |
| all-trans-retinoic acid | increases expression | ISO | RGD:68468 | 6480464 | Tretinoin results in increased expression of POR mRNA | CTD | PMID:16882163 |
| all-trans-retinoic acid | increases expression | ISO | RGD:68468 | 6480464 | Tretinoin results in increased expression of POR mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:68468 | 6480464 | Tretinoin results in increased expression of POR mRNA | CTD | PMID:16882163 PMID:15498508 |
| all-trans-retinoic acid | increases expression | ISO | RGD:68468 | 6480464 | Tretinoin results in increased expression of POR mRNA | CTD | PMID:15498508 PMID:16882163 |
| ametryn | multiple interactions | ISO | RGD:68468 | 6480464 | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] | CTD | PMID:8971136 |
| amiodarone | affects expression | ISO | RGD:68335 | 6480464 | Amiodarone affects the expression of POR mRNA | CTD | PMID:18355885 |
| amitraz | increases activity | ISO | RGD:68335 | 6480464 | amitraz results in increased activity of POR protein | CTD | PMID:15350676 |
| amitriptyline | affects expression | ISO | RGD:68335 | 6480464 | Amitriptyline affects the expression of POR mRNA | CTD | PMID:18355885 |
| ammonium chloride | affects expression | ISO | RGD:68335 | 6480464 | Ammonium Chloride affects the expression of POR mRNA | CTD | PMID:16483693 |
| andrographolide | multiple interactions | EXP | | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of POR mRNA | CTD | PMID:19737545 |
| aristolochic acid | multiple interactions | EXP | | 6480464 | POR protein affects the abundance of and affects the metabolism of aristolochic acid I | CTD | PMID:21362632 |
| aristolochic acid | multiple interactions | EXP | | 6480464 | CYP1A1 protein affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]]; more ... | CTD | PMID:21932800 |
| aristolochic acid | affects abundance | EXP | | 6480464 | POR protein affects the abundance of aristolochic acid I metabolite | CTD | PMID:21362632 |
| Aroclor 1254 | increases expression | ISO | RGD:68335 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of POR protein | CTD | PMID:8471063 |
| Aroclor 1254 | increases expression | ISO | RGD:68335 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of POR mRNA | CTD | PMID:18178546 |
| astaxanthin | increases expression | ISO | RGD:68335 | 6480464 | astaxanthine results in increased expression of POR protein | CTD | PMID:21414371 |
| astaxanthin | decreases activity | ISO | RGD:68335 | 6480464 | astaxanthine results in decreased activity of POR protein | CTD | PMID:21414371 |
| benzo[a]pyrene | decreases expression | ISO | RGD:68468 | 6480464 | Benzo(a)pyrene results in decreased expression of POR mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | POR protein affects the reaction [Benzo(a)pyrene results in increased expression of EPHX1 protein]; more ... | CTD | PMID:22759596 |
| benzo[a]pyrene | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Benzo(a)pyrene | CTD | PMID:21987461 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | POR protein affects the reaction [Benzo(a)pyrene affects the expression of SP1 protein]; more ... | CTD | PMID:21987461 |
| benzo[a]pyrene | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:21376747 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of POR protein] | CTD | PMID:19449198 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of POR protein | CTD | PMID:19449198 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of POR mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | POR protein affects the reaction [Benzo(a)pyrene results in increased activity of and results in increased expression of NQO1 protein] | CTD | PMID:21362632 |
| bezafibrate | increases activity | ISO | RGD:68335 | 6480464 | Bezafibrate results in increased activity of POR protein | CTD | PMID:7606338 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of POR mRNA] | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of POR mRNA | CTD | PMID:19850644 |
| bromobenzene | increases expression | ISO | RGD:68335 | 6480464 | bromobenzene results in increased expression of POR mRNA | CTD | PMID:12628495 |
| C60 fullerene | increases expression | ISO | RGD:68335 | 6480464 | fullerene C60 results in increased expression of POR mRNA | CTD | PMID:19167457 |
| cadmium dichloride | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [Cadmium Chloride results in increased activity of POR protein] | CTD | PMID:20934533 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of POR mRNA | CTD | PMID:11958953 |
| cadmium dichloride | increases activity | ISO | RGD:68468 | 6480464 | Cadmium Chloride results in increased activity of POR protein | CTD | PMID:20934533 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of POR protein] | CTD | PMID:19449198 |
| carbamazepine | increases expression | ISO | RGD:68468 | 6480464 | Carbamazepine results in increased expression of POR mRNA | CTD | PMID:17112801 |
| carvone | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to carvone analog | CTD | PMID:21376747 |
| chloroform | decreases response to substance | EXP | | 6480464 | POR results in decreased susceptibility to Chloroform | CTD | PMID:18031782 |
| cholic acid | increases expression | EXP | | 6480464 | Cholic Acid results in increased expression of POR mRNA | CTD | PMID:17521389 |
| ciglitazone | multiple interactions | ISO | RGD:68468 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of POR mRNA; more ... | CTD | PMID:16197558 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of POR mRNA | CTD | PMID:18353800 |
| cis-ketoconazole | affects expression | ISO | RGD:68335 | 6480464 | Ketoconazole affects the expression of POR mRNA | CTD | PMID:18355885 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of POR mRNA | CTD | PMID:15464296 |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR mRNA | CTD | PMID:15089088 |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR mRNA | CTD | PMID:12851107 more ... |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR mRNA | CTD | PMID:18670166 more ... |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR mRNA | CTD | PMID:15089088 PMID:12851107 |
| clofibrate | increases activity | ISO | RGD:68335 | 6480464 | Clofibrate results in increased activity of POR protein | CTD | PMID:7606338 |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR protein | CTD | PMID:18670166 |
| clofibrate | increases expression | ISO | RGD:68335 | 6480464 | Clofibrate results in increased expression of POR mRNA | CTD | PMID:15089088 more ... |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of POR mRNA | CTD | PMID:17585979 |
| clofibric acid | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POR mRNA | CTD | PMID:17602206 |
| clomipramine | affects expression | ISO | RGD:68335 | 6480464 | Clomipramine affects the expression of POR mRNA | CTD | PMID:18355885 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of POR mRNA | CTD | PMID:21139344 |
| copper atom | multiple interactions | ISO | RGD:68335 | 6480464 | [Nitrofurazone co-treated with POR protein co-treated with Copper] results in increased abundance of 8-oxo-7-hydrodeoxyguanosine | CTD | PMID:15488632 |
| copper atom | decreases expression | ISO | RGD:68335 | 6480464 | Copper results in decreased expression of POR mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | ISO | RGD:68468 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of POR mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:68335 | 6480464 | [Nitrofurazone co-treated with POR protein co-treated with Copper] results in increased abundance of 8-oxo-7-hydrodeoxyguanosine | CTD | PMID:15488632 |
| copper(0) | decreases expression | ISO | RGD:68335 | 6480464 | Copper results in decreased expression of POR mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | ISO | RGD:68468 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of POR mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of POR mRNA | CTD | PMID:18579281 |
| cyclophosphamide | multiple interactions | ISO | RGD:68468 | 6480464 | POR promotes the reaction [CYP2B6 results in increased susceptibility to Cyclophosphamide]; more ... | CTD | PMID:9766669 |
| cyclophosphamide | increases expression | ISO | RGD:68335 | 6480464 | Cyclophosphamide results in increased expression of POR mRNA | CTD | PMID:11599041 |
| cyclophosphamide | multiple interactions | ISO | RGD:68468 | 6480464 | POR protein promotes the reaction [CYP2B6 protein results in increased susceptibility to Cyclophosphamide] | CTD | PMID:10919648 |
| cyclosporin A | decreases expression | ISO | RGD:68468 | 6480464 | Cyclosporine results in decreased expression of POR mRNA | CTD | PMID:20106945 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of POR mRNA | CTD | PMID:16054899 |
| dexamethasone | increases expression | ISO | RGD:68335 | 6480464 | Dexamethasone results in increased expression of POR mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | ISO | RGD:68335 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of POR mRNA] | CTD | PMID:20032058 |
| dibutyl phthalate | decreases expression | ISO | RGD:68335 | 6480464 | Dibutyl Phthalate results in decreased expression of POR mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:68335 | 6480464 | Dibutyl Phthalate results in decreased expression of POR mRNA | CTD | PMID:17379624 PMID:21266533 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydroxyl Radical] | CTD | PMID:21215309 |
| dioxygen | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen]; more ... | CTD | PMID:21215309 |
| dioxygen | increases metabolic processing | ISO | RGD:68468 | 6480464 | [POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen; more ... | CTD | PMID:21215309 |
| diquat | multiple interactions | ISO | RGD:68468 | 6480464 | CAT protein inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:21215309 |
| diquat | multiple interactions | EXP | | 6480464 | CAT protein inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:21215309 |
| diquat | increases metabolic processing | ISO | RGD:68468 | 6480464 | POR protein results in increased metabolism of Diquat; more ... | CTD | PMID:21215309 |
| diquat | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Diquat; more ... | CTD | PMID:21215309 |
| docetaxel anhydrous | increases response to substance | ISO | RGD:68468 | 6480464 | POR mRNA results in increased susceptibility to docetaxel | CTD | PMID:15239142 |
| doxorubicin | decreases response to substance | ISO | RGD:68468 | 6480464 | POR mRNA results in decreased susceptibility to Doxorubicin | CTD | PMID:16322897 |
| doxorubicin | multiple interactions | ISO | RGD:68468 | 6480464 | POR protein affects the metabolism of and results in increased activity of Doxorubicin | CTD | PMID:15942634 |
| elemental selenium | increases expression | ISO | RGD:68468 | 6480464 | Selenium results in increased expression of POR mRNA | CTD | PMID:19244175 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of POR mRNA | CTD | PMID:19167417 |
| fenofibrate | increases expression | ISO | RGD:68335 | 6480464 | Fenofibrate results in increased expression of POR mRNA | CTD | PMID:16707586 |
| ferroheme b | multiple interactions | ISO | RGD:68468 | 6480464 | [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 12-hydroxyellipticine]; more ... | CTD | PMID:22390216 |
| fluconazole | increases expression | EXP | | 6480464 | Fluconazole results in increased expression of POR mRNA | CTD | PMID:16730040 |
| fluconazole | decreases expression | ISO | RGD:68335 | 6480464 | Fluconazole results in decreased expression of POR mRNA | CTD | PMID:16643972 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:68335 | 6480464 | Lindane results in increased expression of POR mRNA | CTD | PMID:17785943 |
| gemfibrozil | increases activity | ISO | RGD:68335 | 6480464 | Gemfibrozil results in increased activity of POR protein | CTD | PMID:7606338 |
| griseofulvin | affects expression | EXP | | 6480464 | Griseofulvin affects the expression of POR mRNA | CTD | PMID:12735108 |
| hesperetin | multiple interactions | ISO | RGD:68335 | 6480464 | hesperetin inhibits the reaction [1,2-Dimethylhydrazine results in increased activity of POR protein] | CTD | PMID:19497424 |
| hexachlorobenzene | decreases expression | ISO | RGD:68335 | 6480464 | Hexachlorobenzene results in decreased expression of POR mRNA | CTD | PMID:15159207 |
| hydrogen peroxide | multiple interactions | ISO | RGD:68468 | 6480464 | [POR protein co-treated with 2-chloroethyl ethyl sulfide] results in increased chemical synthesis of Hydrogen Peroxide; more ... | CTD | PMID:20561902 |
| hydrogen peroxide | multiple interactions | ISO | RGD:68468 | 6480464 | CAT protein inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:21215309 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:21215309 |
| hydrogen peroxide | increases chemical synthesis | ISO | RGD:68468 | 6480464 | POR protein results in increased chemical synthesis of Hydrogen Peroxide | CTD | PMID:20561902 |
| hydroxyl | multiple interactions | ISO | RGD:68468 | 6480464 | [[Iron co-treated with POR protein] results in increased metabolism of Diquat] which results in increased abundance of Hydroxyl Radical; more ... | CTD | PMID:21215309 |
| hydroxyl | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Hydroxyl Radical]; more ... | CTD | PMID:21215309 |
| ifosfamide | multiple interactions | ISO | RGD:68468 | 6480464 | POR promotes the reaction [CYP2B6 results in increased susceptibility to Ifosfamide]; more ... | CTD | PMID:9766669 |
| imipramine | affects expression | ISO | RGD:68335 | 6480464 | Imipramine affects the expression of POR mRNA | CTD | PMID:18355885 |
| iron atom | multiple interactions | ISO | RGD:68468 | 6480464 | [Iron co-treated with POR protein] results in increased metabolism of Diquat; more ... | CTD | PMID:21215309 |
| kojic acid | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; more ... | CTD | PMID:18544905 |
| lipoic acid | multiple interactions | EXP | | 6480464 | CYP1A1 protein affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]]; more ... | CTD | PMID:21932800 |
| lipoic acid | decreases activity | ISO | RGD:68468 | 6480464 | Thioctic Acid results in decreased activity of POR protein | CTD | PMID:16391466 |
| methapyrilene | increases expression | ISO | RGD:68335 | 6480464 | Methapyrilene results in increased expression of POR mRNA | CTD | PMID:15089088 |
| methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of POR mRNA | CTD | PMID:18502557 |
| mitomycin C | increases response to substance | ISO | RGD:68468 | 6480464 | POR mRNA results in increased susceptibility to Mitomycin | CTD | PMID:15239142 |
| mitomycin C | increases response to substance | ISO | RGD:68468 | 6480464 | POR protein results in increased susceptibility to Mitomycin | CTD | PMID:21386838 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68468 | 6480464 | [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine | CTD | PMID:11733072 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of POR mRNA | CTD | PMID:20101389 PMID:19690152 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of POR mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POR mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68335 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of POR mRNA | CTD | PMID:21295105 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of POR mRNA | CTD | PMID:19690152 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of POR mRNA | CTD | PMID:19690152 PMID:20101389 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of POR mRNA; more ... | CTD | PMID:15492232 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:68468 | 6480464 | [CYP2E1 protein co-treated with POR protein] results in increased susceptibility to Diethylnitrosamine | CTD | PMID:11035158 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:68468 | 6480464 | [CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Dimethylnitrosamine | CTD | PMID:11733072 |
| NADP zwitterion | multiple interactions | ISO | RGD:68335 | 6480464 | NADP affects the reaction [POR protein affects the metabolism of Nitrofurantoin] | CTD | PMID:18206659 |
| NADP zwitterion | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP] | CTD | PMID:21215309 |
| NADP zwitterion | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP]; more ... | CTD | PMID:21215309 |
| NADP zwitterion | increases metabolic processing | EXP | | 6480464 | [POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP | CTD | PMID:21215309 |
| NADP zwitterion | increases metabolic processing | ISO | RGD:68468 | 6480464 | [POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP; more ... | CTD | PMID:21215309 |
| NADP zwitterion | multiple interactions | ISO | RGD:68468 | 6480464 | [POR protein co-treated with NADP] results in increased chemical synthesis of Hydrogen Peroxide | CTD | PMID:20561902 |
| NADP zwitterion | multiple interactions | ISO | RGD:68468 | 6480464 | [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 13-hydroxyellipticine]; more ... | CTD | PMID:22390216 |
| NADP zwitterion | multiple interactions | ISO | RGD:68468 | 6480464 | [POR protein co-treated with NADP] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone | CTD | PMID:20545351 |
| NADP(+) | multiple interactions | ISO | RGD:68335 | 6480464 | NADP affects the reaction [POR protein affects the metabolism of Nitrofurantoin] | CTD | PMID:18206659 |
| NADP(+) | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP] | CTD | PMID:21215309 |
| NADP(+) | increases metabolic processing | ISO | RGD:68468 | 6480464 | [POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP; more ... | CTD | PMID:21215309 |
| NADP(+) | increases metabolic processing | EXP | | 6480464 | [POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP | CTD | PMID:21215309 |
| NADP(+) | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of NADP]; more ... | CTD | PMID:21215309 |
| NADP(+) | multiple interactions | ISO | RGD:68468 | 6480464 | [POR protein co-treated with NADP] results in increased chemical synthesis of Hydrogen Peroxide | CTD | PMID:20561902 |
| NADP(+) | multiple interactions | ISO | RGD:68468 | 6480464 | [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 13-hydroxyellipticine]; more ... | CTD | PMID:22390216 |
| NADP(+) | multiple interactions | ISO | RGD:68468 | 6480464 | [POR protein co-treated with NADP] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone | CTD | PMID:20545351 |
| naphthalene | decreases expression | EXP | | 6480464 | naphthalene results in decreased expression of POR protein | CTD | PMID:19438287 |
| nemorubicin | multiple interactions | ISO | RGD:68468 | 6480464 | [CYP3A4 protein co-treated with POR protein] results in increased metabolism of methoxy-morpholinyl-doxorubicin | CTD | PMID:15465924 |
| nitrofurantoin | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Nitrofurantoin | CTD | PMID:18206659 |
| nitrofurantoin | affects metabolic processing | ISO | RGD:68335 | 6480464 | POR protein affects the metabolism of Nitrofurantoin | CTD | PMID:18206659 |
| nitrofurantoin | multiple interactions | ISO | RGD:68335 | 6480464 | NADP affects the reaction [POR protein affects the metabolism of Nitrofurantoin]; more ... | CTD | PMID:18206659 |
| nitrofurantoin | multiple interactions | ISO | RGD:68335 | 6480464 | Nitrofurantoin inhibits the reaction [POR protein results in increased metabolism of Misonidazole] | CTD | PMID:6802140 |
| nitrofurantoin | increases metabolic processing | ISO | RGD:68468 | 6480464 | POR protein results in increased metabolism of Nitrofurantoin | CTD | PMID:18206659 |
| paclitaxel | increases response to substance | ISO | RGD:68468 | 6480464 | POR mRNA results in increased susceptibility to Paclitaxel | CTD | PMID:15239142 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of POR mRNA | CTD | PMID:17562736 |
| paracetamol | affects metabolic processing | EXP | | 6480464 | POR protein affects the metabolism of Acetaminophen | CTD | PMID:15328377 |
| paracetamol | increases expression | ISO | RGD:68468 | 6480464 | Acetaminophen results in increased expression of POR mRNA | CTD | PMID:21420995 |
| paracetamol | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to Acetaminophen | CTD | PMID:15550675 PMID:21376747 |
| paracetamol | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Acetaminophen | CTD | PMID:12566435 |
| paracetamol | increases expression | ISO | RGD:68335 | 6480464 | Acetaminophen results in increased expression of POR mRNA | CTD | PMID:17202762 |
| paracetamol | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to Acetaminophen | CTD | PMID:15550675 |
| paraquat | increases response to substance | ISO | RGD:68468 | 6480464 | POR protein results in increased susceptibility to Paraquat | CTD | PMID:16495354 |
| paraquat | increases expression | ISO | RGD:68335 | 6480464 | Paraquat results in increased expression of POR mRNA | CTD | PMID:17935786 PMID:22846377 |
| paraquat | increases metabolic processing | ISO | RGD:68468 | 6480464 | POR protein results in increased metabolism of Paraquat; more ... | CTD | PMID:21215309 |
| paraquat | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased abundance of Hydrogen Peroxide]; more ... | CTD | PMID:21215309 |
| paraquat | increases expression | ISO | RGD:68335 | 6480464 | Paraquat results in increased expression of POR mRNA | CTD | PMID:17935786 |
| paraquat | multiple interactions | ISO | RGD:68335 | 6480464 | Paraquat promotes the reaction [POR protein results in increased metabolism of Misonidazole] | CTD | PMID:6802140 |
| paraquat | affects expression | ISO | RGD:68335 | 6480464 | Paraquat affects the expression of POR mRNA | CTD | PMID:16854511 |
| paraquat | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to Paraquat | CTD | PMID:16495354 |
| pentachlorophenol | increases expression | ISO | RGD:68468 | 6480464 | Pentachlorophenol results in increased expression of POR mRNA | CTD | PMID:18486366 |
| pentobarbital | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Pentobarbital | CTD | PMID:12697746 PMID:12566435 |
| pentobarbital | affects response to substance | EXP | | 6480464 | POR protein affects the susceptibility to Pentobarbital | CTD | PMID:15328377 |
| pentobarbital | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Pentobarbital | CTD | PMID:12566435 PMID:12697746 |
| pentobarbital | increases export | EXP | | 6480464 | POR protein results in increased export of Pentobarbital | CTD | PMID:12697746 |
| perfluorobutyric acid | increases expression | ISO | RGD:68335 | 6480464 | perfluorobutyric acid analog results in increased expression of POR mRNA | CTD | PMID:21878386 |
| perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of POR mRNA] | CTD | PMID:20936131 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of POR mRNA | CTD | PMID:20936131 |
| perfluorooctanoic acid | affects expression | EXP | | 6480464 | perfluorooctanoic acid affects the expression of POR mRNA | CTD | PMID:18281256 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of POR mRNA | CTD | PMID:18467677 PMID:20936131 |
| perfluorooctanoic acid | increases expression | ISO | RGD:68335 | 6480464 | perfluorooctanoic acid results in increased expression of POR mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of POR mRNA] | CTD | PMID:18467677 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of POR mRNA | CTD | PMID:18467677 |
| phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of POR mRNA; more ... | CTD | PMID:15492232 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR protein | CTD | PMID:23091169 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19270015 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19270015 more ... |
| phenobarbital | affects expression | ISO | RGD:68468 | 6480464 | Phenobarbital affects the expression of POR mRNA | CTD | PMID:19159669 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19270015 more ... |
| phenobarbital | increases expression | ISO | RGD:68468 | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19084549 |
| phenobarbital | increases expression | ISO | RGD:68335 | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19162173 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19482888 more ... |
| phenobarbital | increases expression | ISO | RGD:68335 | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:15089088 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19850644 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19850644 more ... |
| phenobarbital | increases expression | ISO | RGD:68335 | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:15089088 more ... |
| phenobarbital | increases expression | ISO | RGD:68335 | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:12807726 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of POR mRNA | CTD | PMID:19270015 more ... |
| phenobarbital | affects activity | ISO | RGD:68335 | 6480464 | Phenobarbital affects the activity of POR protein | CTD | PMID:12807726 |
| phenobarbital | increases activity | EXP | | 6480464 | Phenobarbital results in increased activity of POR protein | CTD | PMID:12051692 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of POR mRNA] | CTD | PMID:19850644 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of POR mRNA] | CTD | PMID:19482888 |
| phenytoin | increases activity | EXP | | 6480464 | Phenytoin results in increased activity of POR protein | CTD | PMID:12051692 |
| pioglitazone | increases expression | ISO | RGD:68335 | 6480464 | pioglitazone results in increased expression of POR mRNA | CTD | PMID:16597547 |
| piperonyl butoxide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of POR mRNA | CTD | PMID:19690152 PMID:20101389 |
| piperonyl butoxide | increases expression | ISO | RGD:68335 | 6480464 | Piperonyl Butoxide results in increased expression of POR mRNA | CTD | PMID:22484513 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of POR mRNA | CTD | PMID:19690152 PMID:17014948 |
| piperonyl butoxide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of POR mRNA | CTD | PMID:20101389 PMID:19690152 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of POR mRNA | CTD | PMID:17014948 PMID:19690152 |
| piperonyl butoxide | multiple interactions | EXP | | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of POR mRNA | CTD | PMID:19690152 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:19850644 more ... |
| pirinixic acid | increases expression | ISO | RGD:68335 | 6480464 | pirinixic acid results in increased expression of POR mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of POR mRNA] | CTD | PMID:19850644 |
| pirinixic acid | multiple interactions | ISO | RGD:68468 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of POR mRNA | CTD | PMID:19710929 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:68335 | 6480464 | Pregnenolone Carbonitrile results in increased expression of POR mRNA | CTD | PMID:19162173 |
| propiconazole | increases expression | ISO | RGD:68335 | 6480464 | propiconazole results in increased expression of POR mRNA | CTD | PMID:19409404 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of POR mRNA | CTD | PMID:22334560 |
| prostaglandin F2alpha | increases expression | ISO | RGD:68335 | 6480464 | Dinoprost results in increased expression of POR mRNA | CTD | PMID:11517196 |
| quercetin | decreases activity | ISO | RGD:68468 | 6480464 | Quercetin results in decreased activity of POR protein | CTD | PMID:14633740 |
| quercetin | increases activity | ISO | RGD:68468 | 6480464 | Quercetin results in increased activity of POR protein | CTD | PMID:15998352 |
| resveratrol | affects expression | ISO | RGD:68335 | 6480464 | resveratrol affects the expression of POR mRNA | CTD | PMID:15748624 |
| rifampicin | increases activity | EXP | | 6480464 | Rifampin results in increased activity of POR protein | CTD | PMID:12051692 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of POR mRNA | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:68335 | 6480464 | rosiglitazone results in increased expression of POR mRNA | CTD | PMID:16597547 PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:68335 | 6480464 | rosiglitazone results in increased expression of POR mRNA | CTD | PMID:16597547 |
| selenium atom | increases expression | ISO | RGD:68468 | 6480464 | Selenium results in increased expression of POR mRNA | CTD | PMID:19244175 |
| sevoflurane | affects expression | ISO | RGD:68335 | 6480464 | sevoflurane affects the expression of POR mRNA | CTD | PMID:15967596 |
| styrene | increases metabolic processing | EXP | | 6480464 | POR protein results in increased metabolism of Styrene | CTD | PMID:22386858 |
| styrene | increases response to substance | EXP | | 6480464 | POR protein results in increased susceptibility to Styrene | CTD | PMID:22386858 |
| styrene oxide | increases chemical synthesis | EXP | | 6480464 | POR protein results in increased chemical synthesis of styrene oxide | CTD | PMID:22386858 |
| superoxide | multiple interactions | ISO | RGD:68468 | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Superoxides]; more ... | CTD | PMID:21215309 |
| superoxide | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased abundance of Superoxides] | CTD | PMID:21215309 |
| tamibarotene | increases expression | ISO | RGD:68468 | 6480464 | Am 80 results in increased expression of POR mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of POR mRNA | CTD | PMID:20937368 |
| tamoxifen | increases expression | ISO | RGD:68335 | 6480464 | Tamoxifen results in increased expression of POR mRNA | CTD | PMID:15089088 |
| terbutryn | multiple interactions | ISO | RGD:68468 | 6480464 | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] | CTD | PMID:8971136 |
| testosterone | multiple interactions | ISO | RGD:68335 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of POR mRNA] | CTD | PMID:20032058 |
| testosterone | affects metabolic processing | EXP | | 6480464 | POR protein affects the metabolism of Testosterone | CTD | PMID:15328377 |
| toluene | affects expression | ISO | RGD:68335 | 6480464 | Toluene affects the expression of POR mRNA | CTD | PMID:18653662 |
| trans-resveratrol | affects expression | ISO | RGD:68335 | 6480464 | resveratrol affects the expression of POR mRNA | CTD | PMID:15748624 |
| trichloroethene | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of POR mRNA] | CTD | PMID:15363585 |
| troglitazone | increases expression | ISO | RGD:68335 | 6480464 | troglitazone results in increased expression of POR mRNA | CTD | PMID:16597547 |
| troglitazone | increases expression | ISO | RGD:68468 | 6480464 | troglitazone results in increased expression of POR mRNA | CTD | PMID:19631733 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of POR mRNA | CTD | PMID:17292431 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of POR mRNA | CTD | PMID:21427059 PMID:19136453 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of POR mRNA | CTD | PMID:19136453 PMID:21427059 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of POR mRNA | CTD | PMID:21427059 |
| zinc atom | increases expression | ISO | RGD:68335 | 6480464 | Zinc results in increased expression of POR mRNA | CTD | PMID:17074742 |
| zinc atom | increases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in increased expression of POR protein | CTD | PMID:8069767 |
| zinc atom | increases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in increased expression of POR mRNA | CTD | PMID:19111725 |
| zinc atom | decreases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in decreased expression of POR mRNA | CTD | PMID:12672911 |
| zinc pyrithione | decreases expression | ISO | RGD:68468 | 6480464 | zinc pyrithione results in decreased expression of POR mRNA | CTD | PMID:21424779 |
| zinc sulfate | increases expression | ISO | RGD:68335 | 6480464 | Zinc Sulfate results in increased expression of POR mRNA | CTD | PMID:17074742 |
| zinc(0) | increases expression | ISO | RGD:68335 | 6480464 | Zinc results in increased expression of POR mRNA | CTD | PMID:17074742 |
| zinc(0) | decreases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in decreased expression of POR mRNA | CTD | PMID:12672911 |
| zinc(0) | increases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in increased expression of POR mRNA | CTD | PMID:19111725 |
| zinc(0) | increases expression | ISO | RGD:68335 | 6480464 | Zinc deficiency results in increased expression of POR protein | CTD | PMID:8069767 |